Cargando…
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
BACKGROUND: Accurate and timely diagnosis of Alzheimer’s disease (AD) is important for prompt initiation of treatment in patients with AD and to avoid inappropriate treatment of patients with false-positive diagnoses. METHODS: Using a Markov model, we estimated the lifetime costs and quality-adjuste...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356269/ https://www.ncbi.nlm.nih.gov/pubmed/28302164 http://dx.doi.org/10.1186/s13195-017-0243-0 |